Lens Opacities
35
1
3
28
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 35 trials
100.0%
+13.5% vs benchmark
3%
1 trials in Phase 3/4
7%
2 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (35)
Investigation of the Safety and Effectiveness of Monofocal Toric Intraocular Lens (IOL)
Clinical Study to Investigate Outcomes of Trifocal Toric IOL POD FT in Asian Eyes
PMCF Study on EDOF (Isopure) vs Monofocal (Micropure) IOL
Comparison of ISOPURE and EYHANCE (Switzerland)
Clinical Study to Evaluate Clinical Outcomes of LuxSmart IOL as Compared With LuxGood IOL
Multicentric Clinical Study on Isatis TF Trifocal Intraocular Lens
Investigation of the Safety and Effectiveness of a Trifocal IOL
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Europe (PHY2104)
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Spain
PMCF Study on Monofocal Toric IOL (PODEYE TORIC)
PMCF Study on Comparison of EDOF Lenses (Switzerland)
Intraocular Lens Implant Registry Study
Clinical Investigation of the Multifocal IOL POD F GF in Cataracteous Eyes
Comparison of Clinical Outcomes on Trifocal IOLs FineVision POD F GF and FineVision POD F in Asian Eyes
Clinical Investigation of a Monofocal Toric Intra Ocular Lens (IOL) in Cataractous Eyes
Clinical Outcomes of an New EDOF IOL (Isopure®)
Visual Performance Intraocular Lens (IOL) MicroPure 1.2.3.
LensAge to Reveal Biological Age
PMCF Retrospective Study Outcomes of a Monofocal Toric Intraocular Lens